Stephen Noell

机构：Pfizer (United States) · ORCID：0000-0003-3054-2575

发表论文 31 篇 · 总被引 3895 次 · h-index 17

代表论文

• An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19 (2021 · Science · 被引 1996)
• Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19 (2020 · Journal of Medicinal Chemistry · 被引 542)
• Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19 (2021 · Nature Communications · 被引 297)
• Structural basis for the in vitro efficacy of nirmatrelvir against SARS-CoV-2 variants (2022 · Journal of Biological Chemistry · 被引 186)
• Discovery of a Novel Inhibitor of Coronavirus 3CL Protease for the Potential Treatment of COVID-19 (2020 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 159)
• Acoustic Ejection Mass Spectrometry for High-Throughput Analysis (2021 · Analytical Chemistry · 被引 112)